FDA recall record

MESA BIOTECH Accula SARS-CoV-2 Test, REF: COV4100 recall — FDA Z-1009-2022

SARS-CoV-2 Test has an increased potential for false positive results, which may lead to a delay in correct diagnosis and treatment.

Class Iclassification
Z-1009-2022official record ID
May 18, 2022report date

Recall record at a glance

Official recordZ-1009-2022
CategoryMedical Device Recalls
ClassificationClass I
FDA record statusOngoing
Recalling firmMESA BIOTECH, Inc.
Report dateMay 18, 2022
Recall initiation dateApr 6, 2022
Quantity6162
LocationSan Diego, CA, United States

Official product description

Accula SARS-CoV-2 Test, REF: COV4100

Why the product was recalled

SARS-CoV-2 Test has an increased potential for false positive results, which may lead to a delay in correct diagnosis and treatment.

Distribution information

US Nationwide distribution in the states of CA, TX, MA, NY, FL, NC, NJ, GA, CO, HI, PA, WA, NY, VA, MD, KY, WI, IL, PR, ND, MI, TN, AZ, UT.

How to read the classification

FDA Class I indicates a situation in which there is a reasonable probability that use of or exposure to the product will cause serious adverse health consequences or death. The classification shown here comes directly from the FDA enforcement record.

Additional record details

Recall type: Voluntary: Firm initiated. Initial notification: Letter.

What to do next

If you believe you have the recalled product, use the recall number and firm information above to confirm the official notice and follow the instructions issued by the FDA, recalling firm, retailer or product manufacturer. For drugs and medical devices, decisions about treatment or medical care should be discussed with a qualified health professional.

About this record

Recall Lookup USA preserves the most complete source information successfully retrieved. We do not create missing facts or infer affected lots or VINs. The official record may still change, so use the identifier above when verifying current instructions.

FDA source limitation: openFDA enforcement reports are a reference dataset, not a live public-alert or recall-lifecycle service. FDA notes that enforcement-report status may not be updated after classification. Confirm current actions with the FDA, recalling firm or appropriate healthcare professional when relevant.